Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe outer thigh is one of three approved sites for your Mounjaro injection, alongside the abdomen and upper arm. Many people find it the most comfortable spot to reach on their own, and the technique is straightforward once you know what to look for. Mounjaro (tirzepatide) is a prescription-only medicine; your prescriber and the Patient Information Leaflet supplied with your KwikPen are the definitive guides to your personal injection routine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It depends on your situation. The front-outer surface of the thigh (roughly the middle third) gives you a generous area of subcutaneous tissue that is easy to pinch and easy to see. That visibility makes it popular with people injecting for the first time and with anyone who prefers not to involve someone else.
The inner thigh is thinner and more sensitive, so the outer surface is the right area. Avoid the knee and hip joints entirely. If your BMI is lower or you have very little subcutaneous fat on the thigh, your prescriber may suggest the abdomen as a first choice; if it is higher, you may have more options. Either way, there is no single correct site for everyone. You can read more about the full range of Mounjaro injection sites and how each compares.
One thing our prescribers hear most weeks: "does it matter which thigh?" It genuinely does not. Left and right are equivalent. The rule is simply not to use the identical spot two weeks in a row, which is where the rotation principle comes in.
Lipohypertrophy (small, firm fatty lumps under the skin) can build up if the needle repeatedly hits the same patch of tissue. These lumps can affect how the medicine is absorbed, which is a practical reason to rotate rather than a cosmetic one.
A simple approach: mentally divide the outer thigh into a small grid of spots, each about 2–3 centimetres apart, and move to an adjacent spot each week. When you have worked across one thigh, switch to the other, or move to a different site altogether (abdomen or upper arm) before coming back. Keeping a brief note in a diary or phone helps if you are not confident you will remember.
Before injecting, clean the skin with a clean swab and allow it to dry fully, alcohol left on the skin before the needle enters can sting. Individually wrapped sterile swabs are stocked by our pharmacy if you need a reliable supply. Pinch about 2–5 cm of skin gently, hold the KwikPen at a 90-degree angle, press the pen firmly against the skin until the orange cap lifts, and press the purple injection button. Hold for at least ten seconds, then release. The detailed step-by-step process for the thigh specifically is covered on our how to inject Mounjaro in the thigh guide.
Mild redness, a small welt, or brief tenderness at the thigh site after injection is reported by many patients, especially in the early weeks of treatment. These typically fade within hours to a day. Slight bruising is also common and not a cause for concern on its own.
Signs that deserve a call to your prescriber or a pharmacist: a lump that does not flatten after a week or two, persistent itching or swelling, skin that looks thickened or discoloured, or any sign of infection (increasing warmth, discharge, worsening redness spreading from the site). Allergic reactions to the medicine itself (hives, swelling of the face, difficulty breathing) are rare but require immediate medical attention, not a wait-and-see approach.
The NHS tirzepatide guidance notes that injection-site reactions are among the more common side effects of Mounjaro. If reactions at the thigh are consistently more troublesome than at other sites, your prescriber can discuss whether switching your primary site makes sense, and our guide to using the thigh as a tirzepatide injection site covers what to watch for and how to respond. Keeping used needles out of reach and disposing of them in a sharps container matters too; a one-litre sharps bin is the standard option for home use.
Clinical data from the SURMOUNT trials and the medicine's authorisation process show that subcutaneous absorption of tirzepatide is consistent across the three approved sites: thigh, abdomen and upper arm. The Mounjaro SmPC notes no clinically meaningful difference in exposure between sites. So choosing the thigh for comfort or convenience does not compromise the medicine's effectiveness.
What can affect absorption is injecting into an area of significant lipohypertrophy, which is another argument for proper rotation rather than a strict preference for one particular site, and our page on Mounjaro injection sites on the thigh explains how to map out a reliable rotation across the area. You can find storage and handling facts that also touch on injection preparation in our Mounjaro storage conditions guide.
Tirzepatide is a once-weekly subcutaneous injection; the weekly schedule means each site has seven full days to recover before you return to it, which is a generous window. If you are new to injecting into this area, our Mounjaro thigh injection guide walks through everything from positioning to aftercare in straightforward terms. That is something the clinical team at nume can discuss with you as part of your ongoing aftercare.
If you are still deciding whether Mounjaro is the right treatment for you, the weight-loss treatment overview sets out how tirzepatide fits alongside the other licensed options, and what clinical assessment involves. When you are ready, you can check your eligibility through a free consultation with one of our GPhC-registered prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.